DNA Vaccines Market 2022-2028: Industry Analysis, Trends, Growth, Opportunities, and Forecast
The DNA Vaccines Market size is expected to grow at an annual average of 6% during 2022-2028. DNA vaccination is a technology that protects an individual from disease by injecting genetically engineered DNA into an individual, causing the cells to directly produce an antigen to trigger a protective immune response. It consists of using a DNA plasmid as a vector to deliver a gene or fragment thereof encoding an immunogenic antigen to the cells of the host. This approach efficiently induces both humoral and cell-mediated immune responses.
The following segmentation are covered in this report:
By Application
- Veterinary Clinics
- Veterinary Hospitals
By Type
- Therapeutic Vaccines
- Prophylactic Vaccines
Company Profile
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bristol-Myers Squibb Co.
- Gilead Sciences Inc.
- Johnson & Johnson
- Merck & Co.
- Novartis Ag
- Pfizer Inc.
- Sanofi-Aventis
Scope of the report
The research study analyses the DNA Vaccines Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by DNA Vaccines Market Report
- What was the DNA Vaccines Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
- What will be the CAGR of Market during the forecast period (2022-2028)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
- Which manufacturer/vendor/players in the DNA Vaccines Market was the market leader in 2022?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report will be delivered within 48-72 hours after payment confirmation